DeClue JE - Search Results

1

Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.

DeClue JE, Heffelfinger S, Benvenuto G, Ling B, Li S, Rui W, Vass WC, Viskochil D, Ratner N. DeClue JE, et al. J Clin Invest. 2000 May;105(9):1233-41. doi: 10.1172/JCI7610. J Clin Invest. 2000. PMID: 10791998 Free PMC article.

2

Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model.

Li H, Velasco-Miguel S, Vass WC, Parada LF, DeClue JE. Li H, et al. Among authors: declue je. Cancer Res. 2002 Aug 1;62(15):4507-13. Cancer Res. 2002. PMID: 12154062

3

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.

DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR. DeClue JE, et al. Cell. 1992 Apr 17;69(2):265-73. doi: 10.1016/0092-8674(92)90407-4. Cell. 1992. PMID: 1568246

4

Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E-cadherin/beta-catenin activity.

Li S, Braverman R, Li H, Vass WC, Lowy DR, DeClue JE. Li S, et al. Among authors: declue je. Mol Carcinog. 2003 Jun;37(2):98-109. doi: 10.1002/mc.10125. Mol Carcinog. 2003. PMID: 12766909

5

Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.

Ling BC, Wu J, Miller SJ, Monk KR, Shamekh R, Rizvi TA, Decourten-Myers G, Vogel KS, DeClue JE, Ratner N. Ling BC, et al. Among authors: declue je. Cancer Cell. 2005 Jan;7(1):65-75. doi: 10.1016/j.ccr.2004.10.016. Cancer Cell. 2005. PMID: 15652750 Free PMC article.

6

Inhibition of cell growth by lovastatin is independent of ras function.

DeClue JE, Vass WC, Papageorge AG, Lowy DR, Willumsen BM. DeClue JE, et al. Cancer Res. 1991 Jan 15;51(2):712-7. Cancer Res. 1991. PMID: 1985788

7

Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.

Johnson MR, DeClue JE, Felzmann S, Vass WC, Xu G, White R, Lowy DR. Johnson MR, et al. Among authors: declue je. Mol Cell Biol. 1994 Jan;14(1):641-5. doi: 10.1128/mcb.14.1.641-645.1994. Mol Cell Biol. 1994. PMID: 8264632 Free PMC article.

8

Cell transformation by ras and regulation of its protein product.

Lowy DR, Johnson MR, DeClue JE, Cen H, Zhang K, Papageorge AG, Vass WC, Willumsen BM, Valentine MB, Look AT. Lowy DR, et al. Among authors: declue je. Ciba Found Symp. 1993;176:67-80; discussion 80-4. doi: 10.1002/9780470514450.ch5. Ciba Found Symp. 1993. PMID: 8299427 Review.

9

The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.

Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, Halley DJ, Sampson JR, Wienecke R, DeClue JE. Benvenuto G, et al. Among authors: declue je. Oncogene. 2000 Dec 14;19(54):6306-16. doi: 10.1038/sj.onc.1204009. Oncogene. 2000. PMID: 11175345

10

Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus.

DeClue JE, Zhang K, Redford P, Vass WC, Lowy DR. DeClue JE, et al. Mol Cell Biol. 1991 May;11(5):2819-25. doi: 10.1128/mcb.11.5.2819-2825.1991. Mol Cell Biol. 1991. PMID: 2017179 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters